Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 10:26 am Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | VIKING GLOBAL INVESTORS LP | 6,159,146 9.7% | 1,750,000 (+39.69%) | View |
| 2024-02-14 08:43 am Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | Deep Track Capital LP | 2,537,176 4% | -837,218 (-24.81%) | View |
| 2024-02-09 09:03 am Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | FMR LLC | 6,492,513 10.23% | -2,096,716 (-24.41%) | View |
| 2024-02-07 5:09 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | BlackRock Inc. BLK | 3,505,199 4.1% | 198,089 (+5.99%) | View |
| 2024-02-02 3:57 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | BlackRock Inc. BLK | 3,307,110 5.2% | 3,307,110 (New Position) | View |
| 2024-02-01 5:28 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | Flynn James E | 4,478,592 5.25% | 545,455 (+13.87%) | View |
| 2024-01-29 4:30 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | RA CAPITAL MANAGEMENT L.P. | 8,909,091 9.6% | 8,909,091 (New Position) | View |
| 2024-01-25 4:26 pm Purchase | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 6,344,430 7.4% | 272,727 (+4.49%) | View |
| 2024-01-25 4:25 pm Purchase | 13D | EDGEWISE THERAPEUTICS INC EWTX | ORBIMED ADVISORS LLC | 14,756,096 17.3% | 454,545 (+3.18%) | View |
| 2023-06-28 4:17 pm Unchanged | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 6,071,703 9.6% | 0 (Unchanged) | View |
| 2023-02-14 3:06 pm Sale | 13G | EDGEWISE THERAPEUTICS INC EWTX | Cormorant Global Healthcare Master Fund LP | 2,946,887 4.66% | -619,014 (-17.36%) | View |
| 2023-02-14 1:17 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | VIKING GLOBAL INVESTORS LP | 4,409,146 7% | 1,681,897 (+61.67%) | View |
| 2023-02-14 08:14 am Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | CITADEL ADVISORS LLC | 2,849,354 4.5% | 360,070 (+14.46%) | View |
| 2023-02-10 10:01 am Unchanged | 13G | EDGEWISE THERAPEUTICS INC EWTX | Flynn James E | 3,933,137 6.22% | 0 (Unchanged) | View |
| 2023-02-09 10:59 am Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | FMR LLC | 8,589,229 13.587% | 612,416 (+7.68%) | View |
| 2023-02-01 1:38 pm Sale | 13D | EDGEWISE THERAPEUTICS INC EWTX | U.S. Venture Partners XI L.P. | 15,625 0% | -3,473,543 (-99.55%) | View |
| 2022-10-11 09:03 am Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | FMR LLC | 7,976,813 12.631% | 5,476,714 (+219.06%) | View |
| 2022-09-30 4:47 pm Unchanged | 13D | EDGEWISE THERAPEUTICS INC EWTX | Novo Holdings A/S | 6,071,703 9.6% | 0 (Unchanged) | View |
| 2022-09-26 4:06 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | EcoR1 Capital LLC | 3,493,194 5.5% | 3,493,194 (New Position) | View |
| 2022-09-23 4:11 pm Purchase | 13G | EDGEWISE THERAPEUTICS INC EWTX | Deep Track Capital LP | 3,374,394 5.34% | 3,374,394 (New Position) | View |